Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SUHAX vs. XLV: which is better?

Bottom line

SUHAX vs XLV: the short answer

SUHAX (DWS Health and Wellness Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

XLV is cheaper at 0.08% vs 1.34% — a difference of $126 a year per $10,000 invested.

SUHAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

SUHAX vs XLV side by side

SUHAXXLV
TypeMutual fundETF
Fund familyDWS (Xtrackers)SPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.34%0.08%
Annual cost per $10k$134$8
10-yr cost on $10k (prospectus)$2,095$103
Max front load5.75%None
12b-1 fee0.24%0.02%
1-yr return—+14.5%
5-yr return (annualized)—+8.1%
10-yr return (annualized)—+9.8%
Best quarter+17.1%+14.5%
Worst quarter−12.1%−12.7%
Net assets (fund)$231.8M$40.6B
Number of holdings6565
Portfolio turnover2%2%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSUHAXXLVDifference
2025+12.3%+14.5%−2.2%
2024+3.3%+2.5%+0.8%
2023+5.1%+2.0%+3.2%
2022−7.4%−2.1%−5.4%
2021+15.0%+25.9%−10.9%
2020+15.1%+13.3%+1.9%
2019+21.9%+20.7%+1.3%
2018+3.3%+6.3%−3.0%
2017+19.0%+21.7%−2.7%
2016−10.5%−2.8%−7.6%

Source: Fund prospectus bar charts

Holdings overlap

21 of SUHAX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingSUHAXXLV
Eli Lilly & Co13.85%16.51%
Johnson & Johnson6.19%10.64%
UnitedHealth Group Inc5.73%6.57%
AbbVie Inc4.90%7.74%
Merck & Co Inc4.85%5.52%
Thermo Fisher Scientific Inc3.46%3.24%
Amgen Inc2.88%3.40%
Gilead Sciences Inc2.78%2.73%
Intuitive Surgical Inc2.69%2.45%
Stryker Corp2.61%1.89%
Vertex Pharmaceuticals Inc2.45%2.19%
Abbott Laboratories2.39%2.75%
Danaher Corp2.13%2.09%
Boston Scientific Corp2.10%1.10%
McKesson Corp2.05%1.58%

Source: SEC Form N-PORT

SUHAX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between SUHAX and XLV?
SUHAX (DWS Health and Wellness Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.34% — a difference of $126 a year per $10,000 invested.
Which is cheaper, SUHAX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both SUHAX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.